Page last updated: 2024-09-03
amdoxovir and ribavirin
amdoxovir has been researched along with ribavirin in 1 studies
Compound Research Comparison
| Studies (amdoxovir) | Trials (amdoxovir) | Recent Studies (post-2010) (amdoxovir) | Studies (ribavirin) | Trials (ribavirin) | Recent Studies (post-2010) (ribavirin) |
|---|---|---|---|---|---|
| 33 | 5 | 2 | 12,316 | 1,880 | 5,443 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Borroto-Esoda, K; Feng, J; Furman, P; Jeffrey, J; Myrick, F | 1 |
Other Studies
1 other study(ies) available for amdoxovir and ribavirin
| Article | Year |
|---|---|
In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
Topics: Antibiotics, Antineoplastic; Antiviral Agents; Cell Line; Cloning, Molecular; Dioxolanes; DNA, Mitochondrial; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Enzyme Inhibitors; HIV Protease; HIV-1; Humans; IMP Dehydrogenase; Mycophenolic Acid; Purine Nucleosides; Recombinant Proteins; Ribavirin; RNA, Viral | 2004 |